N. Nair

发表

R. Yassa, N. Nair, H. Iskandar, 1988, The Psychiatric clinics of North America.

Therapeutic equivalence of risperidone given once daily and twice daily in patients with schizophrenia. The Risperidone Study Group.

N. Nair, N P Nair, 1998, Journal of clinical psychopharmacology.

Dopamine and Schizophrenia: A Reappraisal in the Light of Clinical Studies with Clozapine *

N. Nair, G. Schwartz, V. Zicherman, 1977, Canadian Psychiatric Association journal.

Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.

D. Bakish, N. Nair, G. Schwartz, 1996, Anxiety.

Differential effect of unilateral and bilateral ECT.

N. Nair, J. J. Fleminger, D. J. D. de Horne, 1970, The American journal of psychiatry.

Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.

N. Nair, S. K. Ahmed, N. Kin, 1993, Journal of psychiatry & neuroscience : JPN.

Beta-Endorphins and Naloxone in Psychiatric Patients: Clinical and Biological Effects

H. Lehmann, N. Kline, N. Nair, 1979 .

Factors in the development of severe forms of tardive dyskinesia.

R. Yassa, N. Nair, G. Schwartz, 1990, The American journal of psychiatry.

Baclofen in the treatment of tardive dyskinesia.

J. Ruiz-Navarro, R. Yassa, N. Nair, 1978, The American journal of psychiatry.

Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo.

C. Katona, N. Klitgaard, P. Kragh‐Sørensen, 1995, Journal of affective disorders.

A Comparison of the Cardiac Safety and Therapeutic Efficacy of Trimipramine versus Doxepin in Geriatric Depressed Patients

J. Thavundayil, N. Nair, N. Nair, 1993, Journal of the American Geriatrics Society.

Clinical Relevance of Serum Nortriptyline and 10-Hydroxy-Nortriptyline Measurements in the Depressed Elderly: A Multicenter Pharmacokinetic and Pharmacodynamic Study

C. Katona, N. Klitgaard, P. Kragh‐Sørensen, 1996, Neuropsychopharmacology.

Neuroleptic-Induced Movement Disorders: Treatment of tardive dyskinesia

D. Jeste, R. Yassa, N. Nair, 1996 .

Comprehensive clinical studies with trazodone.

H. Lehmann, N. Nair, T. Ban, 1973, Current therapeutic research, clinical and experimental.

An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.

G. Uppfeldt, A. Gendron, N. Nair, 1995, Journal of psychiatry & neuroscience : JPN.

Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients

N. Nair, T. E. West, S. K. Ahmed, 1995, Acta psychiatrica Scandinavica. Supplementum.

Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain.

R. L. Singhal, Y. Lapierre, N. Nair, 1980, Advances in biochemical psychopharmacology.

A Double Blind Comparison of Alprazolam and Amitriptyline Hydrochloride in the Treatment of Nonpsychotic Depression

N. Nair, G. Schwartz, B. Suranyi-Cadotte, 1988, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

A 10‐year follow‐up study of tardive dyskinesia

R. Yassa, N. Nair, 1992, Acta psychiatrica Scandinavica.

Proceedings: Penfluridol in the treatment of schizophrenia: clinical and psychometric findings.

N. Nair, M. Deutsch, J. Saarma, 1976, Psychopharmacology bulletin.

A Five-Year Outcome of Discharged Chronic Psychiatric Patients

N. Nair, A. Neufeldt, A. Fakhruddin, 1972, Canadian Psychiatric Association journal.

Drug Therapy of Schizophrenias in the Community

N. Nair, 2007 .

Verapamil in the treatment of chronic schizophrenia.

D. Bloom, N. Nair, S. Tourjman, 1987, Psychopharmacology bulletin.

High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients

D. Bloom, N. Nair, G. Schwartz, 2004, Psychopharmacology.

Secretion of Melatonin in Healthy Elderly Subjects: A Longitudinal Study

N. M. K. Ng Ying Kin, J. Thavundayil, L. Annable, 2004, Annals of the New York Academy of Sciences.

Differences in symptomatology and diagnostic profile in younger and elderly depressed inpatients.

C. Katona, P. Bech, P. Kragh‐Sørensen, 2001, Journal of affective disorders.

The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group.

P. Bech, P. Kragh‐Sørensen, J. K. Larsen, 1997, Journal of affective disorders.

A controlled dose‐ranging study of remoxipride and haloperidol in schizophrenia ‐ a Canadian multicentre trial

C. Durand, P. Sandor, B. Jones, 1990, Acta psychiatrica Scandinavica. Supplementum.

Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.

S. Lal, J. Thavundayil, N. Nair, 1980, Advances in biochemical psychopharmacology.

Trazodone in the treatment of organic brain syndromes, with special reference to psychogeriatrics.

N. Nair, T. Ban, Ban Ta, 1973, Current therapeutic research, clinical and experimental.

The effect of tardive dyskinesia on body weight

R. Yassa, N. Nair, 1987, Acta Psychiatrica Scandinavica.

A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study

J. McClure, R. Remick, D. Bakish, 2005, Psychopharmacology.

beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects.

H. Lehmann, N. Kline, N. Nair, 1979, The American journal of psychiatry.

Efficacy and safety of sabeluzole in patients with probable Alzheimer's disease

I. McKeith, N. Nair, 1994, Neurobiology of Aging.

A dose-range finding study of zopiclone in insomniac patients.

J. Thavundayil, N. Nair, G. Schwartz, 1990, International clinical psychopharmacology.